At the Annual General Meeting of Shareholders of Bioxel Pharma Inc. (TSX VENTURE: BIP), a leading manufacturer of taxane active pharmaceutical ingredients and developer of targeted oncology drugs, the Corporation announced its results for the three-month period ended March 31, 2006.
